21:14

Understanding Clinical Trials

26:36

Genetic Models for CMT

30:24

FDA Direct: Priorities for a New FDA

16:58

Targeting Cytosolic HDAC6 Inhibition for the Treatment of CMT and Beyond

7:34:55

FDA Regulatory Education for Industry (REdI) Annual Conference 2023 – Devices Day 1